Clinical Trials Update: Jan. 12, 2007
Diabetes - Type 1 Vaccines Seizure Disorders
(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:
Diabetes - Type 1
This clinical research study is evaluating an investigational inhaled insulin for treating type 1 diabetes. Volunteers at least 18 years of age who have a diagnosis of type 1 diabetes, have had continuous insulin treatment for at least six months, and have been a nonsmoker for the past six months or longer may qualify.
The research sites are located throughout the United States.
This clinical trial will evaluate an investigational cervical cancer vaccine. Females 11-18 who have not been previously vaccinated against HPV, and are not pregnant or lactating may be included.
The research site is in Rolling Hills Estates, Calif.
This study will evaluate the safety and effectiveness of the novel compound RWJ-333369 in people with partial onset seizures who are currently being treated with one or two concomitant antiepileptic drugs. Candidates must have a history of either partial onset seizure (including either complex partial or partial with secondary generalization, or both) or primarily generalized tonic-clonic seizures for at least one year, with no period of seizure freedom greater than three months in the past year in spite of prior treatment with at least two antiepileptic drugs. People with a history of drug or alcohol abuse within the past two years will not be included.
The research site is in Providence, RI.
Copyright 2007 Thomson CenterWatch. All rights reserved.